A Phosphodiesterase-5 Inhibitor Vardenafil Enhances Angiogenesis Through a Protein Kinase G–Dependent Hypoxia-Inducible Factor-1/Vascular Endothelial Growth Factor Pathway
- 1 July 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (7) , 1315-1324
Abstract
Objective— We examined whether phosphodiesterase-5 (PDE5) inhibition can promote ischemia-induced angiogenesis. Methods and Results— Unilateral hindlimb ischemia was generated by resecting right femoral artery in wild-type C3H/He mice, treated with either vehicle or a PDE5 inhibitor vardenafil (10 mg/kg per day). Four weeks after surgery, vardenafil significantly enhanced blood flow recovery and augmented capillary collateral formation in ischemic muscle (blood flow ratios of ischemic/nonischemic leg: 0.52±0.17 [vehicle] versus 0.92±0.09 [vardenafil], P Conclusion— Our results suggest that PDE5 inhibition enhances ischemia-induced angiogenesis with mobilization of EPCs through a protein kinase G–dependent HIF-1/vascular endothelial growth factor pathway. PDE5 inhibition may have a therapeutic potential to treat ischemic cardiovascular diseases.Keywords
This publication has 30 references indexed in Scilit:
- Role of Circulating Vascular Progenitors in Angiogenesis, Vascular Healing, and Pulmonary HypertensionArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cellsNature Medicine, 2003
- Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle FunctionCirculation Research, 2003
- Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular DiseaseCirculation, 2003
- Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary HypertensionCirculation, 2003
- VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cellsThe EMBO Journal, 1999
- Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitroThe American Journal of Cardiology, 1999
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Mechanisms of angiogenesisNature, 1997
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995